dc.creatorZylbersztajn, Brenda
dc.creatorBarraza, Marlon
dc.creatorTorres, Juan P.
dc.creatorMorales Vallespín, Jorge
dc.date.accessioned2019-03-18T12:01:31Z
dc.date.available2019-03-18T12:01:31Z
dc.date.created2019-03-18T12:01:31Z
dc.date.issued2018
dc.identifierRevista Chilena de Infectologia, Volumen 35, Issue 1, 2018, Pages 22-28
dc.identifier07161018
dc.identifier10.4067/s0716-10182018000100022
dc.identifierhttps://repositorio.uchile.cl/handle/2250/167417
dc.description.abstract© 2018, Sociedad Chilena de Infectologia. All rights reserved. This review summarizes recommendations of therapeutic monitoring of three antimicrobials based in regional data: vancomycin, amikacin and voriconazole in pediatric population. Regional evidence agrees with international literature regarding the requirement of higher daily doses than 40 mg/kg/day of vancomycin, as well as with the possibility of use one daily doses of amikacin and to recommend higher doses of voriconazole compared to the initially recommended doses of 8 mg/kg/day. Local data on the pharmacokinetic/pharmacodynamic behavior of various antimicrobials in pediatrics are of great value for dosing adjustment in our pediatric population. More studies in therapeutic monitoring in the use of antimicrobials in pediatrics should be performed in order to allow the generation of adequate treatment guidelines for this age group.
dc.languageen
dc.publisherSociedad Chilena de Infectologia
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceRevista Chilena de Infectologia
dc.subjectAntimicrobials
dc.subjectPharmacokinetics
dc.subjectTherapeutic monitoring
dc.titleTherapeutic monitoring of antimicrobial agents in pediatrics. Review based on Latin Am erican experiences Monitorización terapéutica de antimicrobianos en pediatría. Revisión de la experiencia latinoamericana
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución